NCT06317207Completed
Evaluation of the Safety of Reoperation for Ipsilateral Recurrent Tumors After Nephron-sparing Partial Nephrectomy
Reoperation for Ipsilateral Local Recurrence Following Prior Nephron-sparing Surgery: Innovative Surgical Insights From a High-volume Urological Center
Source: ClinicalTrials.gov · Last updated 19 Mar 2024
Brief summary (registry, in English)
To evaluate the safety of reoperation in patients with renal tumors who have ipsilateral tumor recurrence after nephron-sparing partial nephrectomy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 15 (actual)
- First submitted
- 9 Mar 2024
- Start date
- 1 Jan 2013
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- The First Affiliated Hospital of Anhui Medical University
- Diseases
- Kidney cancer, Childhood cancers
- NCT number
- NCT06317207
What you commit to
- Study type: Observational
- Participants enrolled: 15
- From 1 Jan 2013 to the primary completion date, 31 Dec 2023
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- With distant metastasis;
- Lacking essential sugery information.
Who the study is looking for
- 1\. ipsilateral local rRCC (any recurrence in the ipsilateral kidney and retroperitoneum)
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.